Sequencing Strategy Detects Rearrangements, Could Find Use in Personalized Cancer Treatment

The researchers, led by Johns Hopkins University, said the method could be used to identify patient-specific "personalized biomarkers" that could be used to monitor tumor response to specific therapies.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories